Eiichi Katsumoto

506 total citations
26 papers, 159 citations indexed

About

Eiichi Katsumoto is a scholar working on Psychiatry and Mental health, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Eiichi Katsumoto has authored 26 papers receiving a total of 159 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Psychiatry and Mental health, 6 papers in Cellular and Molecular Neuroscience and 5 papers in Molecular Biology. Recurrent topics in Eiichi Katsumoto's work include Bipolar Disorder and Treatment (13 papers), Electroconvulsive Therapy Studies (11 papers) and Schizophrenia research and treatment (6 papers). Eiichi Katsumoto is often cited by papers focused on Bipolar Disorder and Treatment (13 papers), Electroconvulsive Therapy Studies (11 papers) and Schizophrenia research and treatment (6 papers). Eiichi Katsumoto collaborates with scholars based in Japan and United States. Eiichi Katsumoto's co-authors include Takashi Tsuboi, Seiji Hongo, Norio Yasui‐Furukori, Koichiro Watanabe, Sakae Yamagami, Toshiaki Kikuchi, Masaki Kato, Takaharu Azekawa, Atsuo Nakagawa and Reiji Yoshimura and has published in prestigious journals such as PLoS ONE, Neuroscience and International Journal of Environmental Research and Public Health.

In The Last Decade

Eiichi Katsumoto

25 papers receiving 157 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eiichi Katsumoto Japan 8 118 19 18 18 15 26 159
Zhaoyu Gan China 9 112 0.9× 15 0.8× 22 1.2× 23 1.3× 25 1.7× 25 178
Stevin Zung Brazil 7 84 0.7× 17 0.9× 18 1.0× 12 0.7× 13 0.9× 18 149
A. Aldama Spain 7 161 1.4× 27 1.4× 7 0.4× 67 3.7× 16 1.1× 7 210
Marc L. M. van der Loos Netherlands 6 292 2.5× 12 0.6× 38 2.1× 24 1.3× 4 0.3× 6 325
Sebastian Kliwicki Poland 5 111 0.9× 12 0.6× 12 0.7× 26 1.4× 11 0.7× 6 162
Vasavan Nair Canada 8 172 1.5× 10 0.5× 13 0.7× 25 1.4× 4 0.3× 13 208
Sieglinde C. Othmer United States 8 89 0.8× 17 0.9× 9 0.5× 31 1.7× 25 1.7× 15 213
Karen E. Anderson United States 5 97 0.8× 38 2.0× 14 0.8× 20 1.1× 22 1.5× 6 195
Nick Craddock United Kingdom 4 71 0.6× 9 0.5× 8 0.4× 26 1.4× 9 0.6× 6 118
Jan‐Marie Kozicky Canada 8 187 1.6× 5 0.3× 10 0.6× 34 1.9× 4 0.3× 10 218

Countries citing papers authored by Eiichi Katsumoto

Since Specialization
Citations

This map shows the geographic impact of Eiichi Katsumoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eiichi Katsumoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eiichi Katsumoto more than expected).

Fields of papers citing papers by Eiichi Katsumoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eiichi Katsumoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eiichi Katsumoto. The network helps show where Eiichi Katsumoto may publish in the future.

Co-authorship network of co-authors of Eiichi Katsumoto

This figure shows the co-authorship network connecting the top 25 collaborators of Eiichi Katsumoto. A scholar is included among the top collaborators of Eiichi Katsumoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eiichi Katsumoto. Eiichi Katsumoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Adachi, Naoto, Koichiro Watanabe, Reiji Yoshimura, et al.. (2023). Costs of psychotropics for outpatients with bipolar disorder in Japan; the MUSUBI 2016 survey. Annals of Medicine. 55(1). 2224047–2224047. 1 indexed citations
2.
Yasui‐Furukori, Norio, Naoto Adachi, Yoichiro Watanabe, et al.. (2023). Predictors of psychiatric hospitalization among outpatients with bipolar disorder in the real-world clinical setting. Frontiers in Psychiatry. 14. 1078045–1078045. 6 indexed citations
3.
4.
Sugawara, Norio, Naoto Adachi, Yoichiro Watanabe, et al.. (2022). Determinants of three-year clinical outcomes in real-world outpatients with bipolar disorder: The multicenter treatment survey for bipolar disorder in psychiatric outpatient clinics (MUSUBI). Journal of Psychiatric Research. 151. 683–692. 3 indexed citations
5.
Yasui‐Furukori, Norio, Naoto Adachi, Hitoshi Ueda, et al.. (2022). Effect of age and sex on prescriptions for outpatients with bipolar disorder in the MUSUBI study: a cross‑sectional study. Annals of General Psychiatry. 21(1). 37–37. 2 indexed citations
6.
Konno, Yusuke, Yoshihisa Fujino, Atsuko Ikenouchi, et al.. (2021). Relationship Between Mood Episode and Employment Status of Outpatients with Bipolar Disorder: Retrospective Cohort Study from the Multicenter Treatment Survey for Bipolar Disorder in Psychiatric Clinics (MUSUBI) Project. Neuropsychiatric Disease and Treatment. Volume 17. 2867–2876. 5 indexed citations
7.
Yasui‐Furukori, Norio, Naoto Adachi, Yoichiro Watanabe, et al.. (2021). Real-world clinical predictors of manic/hypomanic episodes among outpatients with bipolar disorder. PLoS ONE. 16(12). e0262129–e0262129. 7 indexed citations
8.
Katsumoto, Eiichi, Toru Ishida, Kenji Kinoshita, et al.. (2021). Yokukansankachimpihange Is Useful to Treat Behavioral/Psychological Symptoms of Dementia. Frontiers in Nutrition. 7. 529390–529390. 4 indexed citations
9.
Yasui‐Furukori, Norio, Naoto Adachi, Hitoshi Ueda, et al.. (2021). Differences in prescription patterns between real-world outpatients with bipolar I and II disorders in the MUSUBI survey. Asian Journal of Psychiatry. 67. 102935–102935. 10 indexed citations
10.
Yasui‐Furukori, Norio, Naoto Adachi, Takaharu Azekawa, et al.. (2020). Factors Associated with Doses of Mood Stabilizers in Real-world Outpatients with Bipolar Disorder. Clinical Psychopharmacology and Neuroscience. 18(4). 599–606. 10 indexed citations
11.
Kato, Masaki, Naoto Adachi, Takaharu Azekawa, et al.. (2020). Clinical features related to rapid cycling and one-year euthymia in bipolar disorder patients: A multicenter treatment survey for bipolar disorder in psychiatric clinics (MUSUBI). Journal of Psychiatric Research. 131. 228–234. 15 indexed citations
12.
Yasui‐Furukori, Norio, Naoto Adachi, Yoichiro Watanabe, et al.. (2020). Real-world clinical features of and antidepressant prescribing patterns for outpatients with bipolar disorder. BMC Psychiatry. 20(1). 555–555. 16 indexed citations
13.
Katsumoto, Eiichi, et al.. (2000). Alterations of Glutamate Transporter Gene Expression in Epileptic EL Mice Brains. Epilepsia. 41(s9). 55–56. 6 indexed citations
14.
Katsumoto, Eiichi, et al.. (1998). Distribution of Fos- and Jun-related proteins and activator protein-1 composite factors in mouse brain induced by neuroleptics. Neuroscience. 84(4). 1187–1196. 13 indexed citations
15.
Katsumoto, Eiichi, et al.. (1997). The comparative effects of haloperidol, (−)-sulpiride, and SCH23390 on c-fos and c-jun mRNA expressions, and AP-1 DNA binding activity. European Neuropsychopharmacology. 7(3). 181–187. 9 indexed citations
16.
Katsumoto, Eiichi, et al.. (1996). Alteration of Fos‐and Jun‐Related Antigens After Seizures in Epileptic EL Mice.. Epilepsia. 37(s3). 103–103. 1 indexed citations
17.
Katsumoto, Eiichi, et al.. (1995). P-4-6 The effect of neuroleptics on the AP-1 DNA binding activity and the induction of fos and jun. European Neuropsychopharmacology. 5(3). 328–328. 1 indexed citations
18.
Yokotani, Noboru, et al.. (1994). The difference among effects of haloperidol, (−)-sulpiride and SCH23390 on the expression of c-fos and c-jun mRNA inductions. European Neuropsychopharmacology. 4(3). 365–365. 1 indexed citations
19.
Katsumoto, Eiichi, et al.. (1993). Induction of c-fos mRNA Expression in the Brain by Seizures of Seizure-susceptible E1 mice.. Journal of the Japan Epilepsy Society. 11(1). 1–8.
20.
Katsumoto, Eiichi, et al.. (1992). COMPARATIVE EFFECTS OF HALOPERIDOL AND SULPIRIDE ON c-fos mRNA EXPRESSION OF MOUSE BRAIN.. Clinical Neuropharmacology. 15. 578B–578B. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhaoyu Gan Breakdown of academic impact, for papers by Stevin Zung Breakdown of academic impact, for papers by A. Aldama Breakdown of academic impact, for papers by Marc L. M. van der Loos Breakdown of academic impact, for papers by Sebastian Kliwicki Breakdown of academic impact, for papers by Vasavan Nair Breakdown of academic impact, for papers by Sieglinde C. Othmer Breakdown of academic impact, for papers by Karen E. Anderson Breakdown of academic impact, for papers by Nick Craddock Breakdown of academic impact, for papers by Jan‐Marie Kozicky
Rankless by CCL
2026